NXTS Stock Chart & Stats
$4.12
$0.60(43.80%)
At close: 4:00 PM EST
$4.12
$0.60(43.80%)
Day’s Range― - ―
52-Week Range$3.38 - $89.80
Previous CloseN/A
VolumeN/A
Average Volume (3M)23.72K
Market Cap
$6.25M
Enterprise Value$1.15M
Total Cash (Recent Filing)$6.24M
Total Debt (Recent Filing)$473.00K
Price to Earnings (P/E)―
Beta-0.06
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-16.69
Shares Outstanding1,453,333
10 Day Avg. Volume29,284
30 Day Avg. Volume23,723
Financial Highlights & Ratios
PEG Ratio0.02
Price to Book (P/B)0.10
Price to Sales (P/S)0.00
P/FCF Ratio-0.43
Enterprise Value/Market Cap0.18
Enterprise Value/Revenue-17.43
Enterprise Value/Gross Profit-16.44
Enterprise Value/Ebitda-0.11
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Nexentis Technologies News
NXTS FAQ
What was Nexentis Technologies’s price range in the past 12 months?
Nexentis Technologies lowest stock price was $3.38 and its highest was $89.80 in the past 12 months.
What is Nexentis Technologies’s market cap?
Nexentis Technologies’s market cap is $6.25M.
When is Nexentis Technologies’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Nexentis Technologies’s earnings last quarter?
Currently, no data Available
Is Nexentis Technologies overvalued?
According to Wall Street analysts Nexentis Technologies’s price is currently Overvalued.
Does Nexentis Technologies pay dividends?
Nexentis Technologies does not currently pay dividends.
What is Nexentis Technologies’s EPS estimate?
Nexentis Technologies’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Nexentis Technologies have?
Nexentis Technologies has 1,453,333 shares outstanding.
What happened to Nexentis Technologies’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Nexentis Technologies?
Currently, no hedge funds are holding shares in NXTS
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Nexentis Technologies
Nexentis Technologies Inc., through its subsidiary, develops therapeutics related to cancer and inflammatory metabolic diseases. It operates through two segments, Biotechnology Activity and Renewable Energy Projects. The company's pipeline includes MITOLINE, an algorithm used to perform multiple sequence/ structure pairwise alignments which could then be used for generating a 3D comparative model of potentially all mitochondrial carrier proteins; cloud-based computational chemistry platform; and novel in-vitro screening platforms; and advanced 3D NSCLC tumor spheroid systems.The company was formerly known as N2OFF, Inc. and changed its name to Nexentis Technologies Inc. in February 2026. Nexentis Technologies Inc. was incorporated in 2009 and is headquartered in Ness Ziona, Israel.
Technical Analysis
American Vanguard
―
Enlightify
―
Origin Agritech
―
Arcadia Biosciences
―
Bioceres Crop Solutions
―
Ownership Overview
Options Prices
Currently, No data available
---